Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Jean-Luc Vanderheyden"'
Autor:
Anne M. Smith, Nancy A. Obuchowski, Norman L. Foster, Gregory Klein, P. David Mozley, Adriaan A. Lammertsma, Richard L. Wahl, John J. Sunderland, Jean-Luc Vanderheyden, Tammie L.S. Benzinger, Paul E. Kinahan, Dean F. Wong, Eric S. Perlman, Satoshi Minoshima, Dawn Matthews
Publikováno v:
Smith, A M, Obuchowski, N A, Foster, N L, Klein, G, Mozley, P D, Lammertsma, A A, Wahl, R L, Sunderland, J J, Vanderheyden, J-L, Benzinger, T L S, Kinahan, P E, Wong, D F, Perlman, E S, Minoshima, S & Matthews, D 2023, ' The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification ', Journal of Nuclear Medicine, vol. 64, no. 2, pp. 294-303 . https://doi.org/10.2967/jnumed.122.264031
A standardized approach to acquiring amyloid PET images increases their value as disease and drug response biomarkers. Most 18F PET amyloid brain scans often are assessed only visually (per regulatory labels), with a binary decision indicating the pr
Autor:
Tarik Belhocine, Jean-Luc Vanderheyden
Publikováno v:
Current Molecular Imaging. 3:52-63
Autor:
Ruth Oltenfreiter, Jean-Luc Vanderheyden, Guido Slegers, Ingrid Burvenich, Otto C. Boerman, Bart Cornelissen, Veerle Kersemans, Christophe Vandewiele
Publikováno v:
Nuclear Medicine Communications, 26, 147-53
Nuclear Medicine Communications, 26, 2, pp. 147-53
Nuclear Medicine Communications, 26, 2, pp. 147-53
Contains fulltext : 48444.pdf (Publisher’s version ) (Closed access) OBJECTIVE: The goal of this study was to develop a 99mTc labelled human epidermal growth factor (hEGF) for the in-vivo prediction of cancer cell response to farnesyltransferase in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf298c6121a52d3b6c9dce3e87208632
https://ora.ox.ac.uk/objects/uuid:de98adcb-c323-4b41-b05c-43af0de1300a
https://ora.ox.ac.uk/objects/uuid:de98adcb-c323-4b41-b05c-43af0de1300a
Autor:
Bengt Långström, Arcadius V. Krivoshein, Irina Velikyan, Manoj Nair, Elisabeth Blom, Azita Monazzam, Jean-Luc Vanderheyden, Marina V. Backer, Payam Razifar, Pasha Razifar, Joseph M. Backer
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 54:685-692
Vascular endothelial growth factor (VEGF) signaling via vascular endothelial growth factor receptor 2 (VEGFR-2) on tumor endothelial cells is a critical driver of tumor angiogenesis. Novel anti-ang ...
Autor:
Jun Zhou, Masayoshi Sarai, Nathan D. Wong, Shinichiro Fujimoto, Navneet Narula, Sudhir Gupta, Dagmar Hartung, Frank D. Kolodgie, Jagat Narula, Chris P. M. Reutelingsperger, Jean-Luc Vanderheyden, Leonard Hofstra, Artiom Petrov, Renu Virmani, Satoshi Isobe
Publikováno v:
Journal of the American College of Cardiology. 50:2305-2312
ObjectivesThe purpose of this study was to evaluate the role of caspase inhibitors on acute resolution of apoptosis in atherosclerotic lesions as evaluated by imaging with annexin A5.BackgroundExtensive apoptosis of macrophages has been reported at t
Autor:
Jean-Luc Vanderheyden, Gunnar Antoni, Michael Christopher Montalto, Marivi Mendizabal, Bengt Långström, Richard A. Frank, Eric D. Agdeppa, Ian Andrew Wilson
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 50:746-769
Innovation in basic and applied science has brought radiotracers to fruition as diagnostics. Non-invasive, longitudinal, and quantifiable molecular imaging is the key to diagnosing and monitoring numerous illnesses, with more to come from characteriz
Autor:
Takahiro Higuchi, Jean-Luc Vanderheyden, Muramori A, Ichiro Matsunari, H. William Strauss, Kenichi Nakajima, Jonathan F. Tait, Atsuhiro Kawashima, Junichi Taki
Publikováno v:
Circulation Journal. 71(7):1141-1146
金沢大学医学部附属病院核医学診療科
Background: To determine whether mild to moderate ischemia that is not severe enough to induce myocardial infarction will cause myocardial cell damage or apoptosis, the 99mTc-Annexin-V (Tc-A) u
Background: To determine whether mild to moderate ischemia that is not severe enough to induce myocardial infarction will cause myocardial cell damage or apoptosis, the 99mTc-Annexin-V (Tc-A) u
Autor:
Francis G. Blankenberg, Christophe Van de Wiele, Larry Stitt, Frank J. P. Hoebers, Jean-Luc Vanderheyden, Marina Kartachova, Tarik Belhocine
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 42(13), 2083-2097. Springer, Cham
99mTc-Annexin A5 has been used as a molecular imaging probe for the visualization, characterization and measurement of apoptosis. In an effort to define the quantitative 99mTc-annexin A5 uptake criteria that best predict tumor response to treatment,
Autor:
Maya A. Koike, Allan M. Green, Jean-Luc Vanderheyden, Judy E. Kalinyak, Michael L. Goris, Francis G. Blankenberg, Midori A. Yenari, Danye Cheng, Liping Liu, David C. Tong
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 33:566-574
The first aim of the study was to determine whether 99mTc-HYNIC-annexin V, a marker of cellular stress and apoptosis, can detect ischemic injury in patients with acute stroke. Secondly, we wished to test radiolabeled annexin’s ability to monitor th
Autor:
Jiang He, Ching-Hsuan Tung, Guozheng Liu, Ning Liu, Jean-Luc Vanderheyden, Ivan Yanachkov, Mary Rusckowski, Yu-Min Zhang
Publikováno v:
Nuclear Medicine and Biology. 33:263-269
The attempt to target the limited copies of messenger RNA (mRNA) in vivo with radiolabeled nucleobase oligomers as antisense probes is challenging. Selecting an antisense molecule with superior properties, enhancing the cellular kinetics, and improvi